These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 21410249)

  • 1. Capturing structure-activity relationships from chemogenomic spaces.
    Wendt B; Uhrig U; Bös F
    J Chem Inf Model; 2011 Apr; 51(4):843-51. PubMed ID: 21410249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Making every SAR point count: the development of Chemistry Connect for the large-scale integration of structure and bioactivity data.
    Muresan S; Petrov P; Southan C; Kjellberg MJ; Kogej T; Tyrchan C; Varkonyi P; Xie PH
    Drug Discov Today; 2011 Dec; 16(23-24):1019-30. PubMed ID: 22024215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global mapping of pharmacological space.
    Paolini GV; Shapland RH; van Hoorn WP; Mason JS; Hopkins AL
    Nat Biotechnol; 2006 Jul; 24(7):805-15. PubMed ID: 16841068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From activity cliffs to activity ridges: informative data structures for SAR analysis.
    Vogt M; Huang Y; Bajorath J
    J Chem Inf Model; 2011 Aug; 51(8):1848-56. PubMed ID: 21761918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Large-scale similarity search profiling of ChEMBL compound data sets.
    Heikamp K; Bajorath J
    J Chem Inf Model; 2011 Aug; 51(8):1831-9. PubMed ID: 21728295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virtual screening for R-groups, including predicted pIC50 contributions, within large structural databases, using Topomer CoMFA.
    Cramer RD; Cruz P; Stahl G; Curtiss WC; Campbell B; Masek BB; Soltanshahi F
    J Chem Inf Model; 2008 Nov; 48(11):2180-95. PubMed ID: 18956863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotography for multi-target SAR analysis in the context of biological pathways.
    Lounkine E; Kutchukian P; Petrone P; Davies JW; Glick M
    Bioorg Med Chem; 2012 Sep; 20(18):5416-27. PubMed ID: 22405595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A data mining method to facilitate SAR transfer.
    Wassermann AM; Bajorath J
    J Chem Inf Model; 2011 Aug; 51(8):1857-66. PubMed ID: 21774471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SAR Matrix Method for Large-Scale Analysis of Compound Structure-Activity Relationships and Exploration of Multitarget Activity Spaces.
    Hu Y; Bajorath J
    Methods Mol Biol; 2018; 1825():339-352. PubMed ID: 30334212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assay Related Target Similarity (ARTS) - chemogenomics approach for quantitative comparison of biological targets.
    Bieler M; Heilker R; Köppen H; Schneider G
    J Chem Inf Model; 2011 Aug; 51(8):1897-905. PubMed ID: 21761911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Importance of molecular computer modeling in anticancer drug development.
    Geromichalos GD
    J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A relational learning approach to Structure-Activity Relationships in drug design toxicity studies.
    Camacho R; Pereira M; Costa VS; Fonseca NA; Adriano C; Simões CJ; Brito RM
    J Integr Bioinform; 2011 Sep; 8(3):182. PubMed ID: 21926445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural interpretation of activity cliffs revealed by systematic analysis of structure-activity relationships in analog series.
    Sisay MT; Peltason L; Bajorath J
    J Chem Inf Model; 2009 Oct; 49(10):2179-89. PubMed ID: 19761254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computational tools for polypharmacology and repurposing.
    Achenbach J; Tiikkainen P; Franke L; Proschak E
    Future Med Chem; 2011 Jun; 3(8):961-8. PubMed ID: 21707399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In silico carborane docking to proteins and potential drug targets.
    Calvaresi M; Zerbetto F
    J Chem Inf Model; 2011 Aug; 51(8):1882-96. PubMed ID: 21774557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of pharmacology data and the prediction of adverse drug reactions and off-target effects from chemical structure.
    Bender A; Scheiber J; Glick M; Davies JW; Azzaoui K; Hamon J; Urban L; Whitebread S; Jenkins JL
    ChemMedChem; 2007 Jun; 2(6):861-73. PubMed ID: 17477341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Data structures and computational tools for the extraction of SAR information from large compound sets.
    Wawer M; Lounkine E; Wassermann AM; Bajorath J
    Drug Discov Today; 2010 Aug; 15(15-16):630-9. PubMed ID: 20547243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computational methodologies for compound database searching that utilize experimental protein-ligand interaction information.
    Tan L; Batista J; Bajorath J
    Chem Biol Drug Des; 2010 Sep; 76(3):191-200. PubMed ID: 20636330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding and predicting druggability. A high-throughput method for detection of drug binding sites.
    Schmidtke P; Barril X
    J Med Chem; 2010 Aug; 53(15):5858-67. PubMed ID: 20684613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.